K
Katri Rosenthal-Aizman
Researcher at Stockholm University
Publications - 8
Citations - 872
Katri Rosenthal-Aizman is an academic researcher from Stockholm University. The author has contributed to research in topics: Membrane & Cyclic peptide. The author has an hindex of 6, co-authored 8 publications receiving 797 citations.
Papers
More filters
Journal ArticleDOI
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
Samir El Andaloussi,Taavi Lehto,Imre Mäger,Katri Rosenthal-Aizman,Iulian I. Oprea,Oscar E. Simonson,Helena Sork,Kariem Ezzat,Dana Copolovici,Kaido Kurrikoff,Joana R Viola,Eman M. Zaghloul,Rannar Sillard,Henrik J. Johansson,Fatouma Said Hassane,Peter Guterstam,Julia Suhorutsenko,Pedro Moreno,Nikita Oskolkov,Jonas Hälldin,Ulf Tedebark,Andres Metspalu,Bernard Lebleu,Janne Lehtiö,C. I. Edvard Smith,Ülo Langel +25 more
TL;DR: A novel CPP, PepFect 6 (PF6), comprising the previously reported stearyl-TP10 peptide, having pH titratable trifluoromethylquinoline moieties covalently incorporated to facilitate endosomal release is presented, implying that the peptides, in addition to having utility for RNAi screens in vitro, displays therapeutic potential.
Journal ArticleDOI
Cell-penetrating peptides: A comparative membrane toxicity study
Külliki Saar,Maria Lindgren,Mats Hansen,Emelía Eiríksdóttir,Yang Jiang,Katri Rosenthal-Aizman,Meeri Sassian,Meeri Sassian,Ülo Langel +8 more
TL;DR: In this article, a new class of delivery vectors with high pharmaceutical potential, called cell-penetrating peptides (CPPs), were proposed. But the ability of these peptides to translocate through cell membranes can be limited.
Journal ArticleDOI
Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.
Maria Lindgren,Katri Rosenthal-Aizman,Külliki Saar,Emelía Eiríksdóttir,Yang Jiang,Meeri Sassian,Pernilla Östlund,Mattias Hällbrink,Ülo Langel +8 more
TL;DR: Cell-penetrating peptide conjugation of MTX is a new way of increasing delivery, and thereby, the potency of already well-characterized therapeutic molecules into drug resistant tumour cells.
Journal ArticleDOI
Self-Assembling Peptide Nanotubes from Enantiomeric Pairs of Cyclic Peptides with Alternating d and l Amino Acid Residues
TL;DR: Results strongly indicate the formation of peptide nanotubes that assemble with one enantiomer in every second position, thereby forming a lamellar structure.
Journal ArticleDOI
Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
Maija Hyvönen,Juulia Enbäck,Tuulia Huhtala,Johanna Lammi,Harri Sihto,Janne Weisell,Heikki Joensuu,Katri Rosenthal-Aizman,Samir El-Andaloussi,Ülo Langel,Ale Närvänen,Gabriele Bergers,Pirjo Laakkonen +12 more
TL;DR: In this article, a novel homing peptide that recognizes tumor vessels and invasive tumor satellites in glioblastomas was identified, and the peptide-targeted delivery of chemotherapeutics prolonged the lifespan of mice bearing invasive brain tumors and significantly reduced the number of tumor satellites.